trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol

C16H26BrN5O2Si — CID 140776898

IUPACtrans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol
SMILESC[Si](C)(C)CCOCn1nc(Br)c2c(N[C@@H]3CCC[C@H]3O)ncnc21
InChIInChI=1S/C16H26BrN5O2Si/c1-25(2,3)8-7-24-10-22-16-13(14(17)21-22)15(18-9-19-16)20-11-5-4-6-12(11)23/h9,11-12,23H,4-8,10H2,1-3H3,(H,18,19,20)/t11-,12-/m1/s1
InChIKeyLIXLKDPJQBKEEG-VXGBXAGGSA-N
MW428.41 g/mol
LogP3.23
Rot. Bonds7

About trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol

trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol (PubChem CID 140776898) has the molecular formula C16H26BrN5O2Si and a molecular weight of 428.41 g/mol. Its IUPAC name is trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol.

Molecular Properties

Compound Nametrans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol
PubChem CID140776898
Molecular FormulaC16H26BrN5O2Si
Molecular Weight428.41 g/mol
Exact Mass427.10
IUPAC Nametrans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol
SMILESC[Si](C)(C)CCOCn1nc(Br)c2c(N[C@@H]3CCC[C@H]3O)ncnc21
InChIInChI=1S/C16H26BrN5O2Si/c1-25(2,3)8-7-24-10-22-16-13(14(17)21-22)15(18-9-19-16)20-11-5-4-6-12(11)23/h9,11-12,23H,4-8,10H2,1-3H3,(H,18,19,20)/t11-,12-/m1/s1
InChIKeyLIXLKDPJQBKEEG-VXGBXAGGSA-N
XLogP3.23
TPSA85.09 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500428.41
LogP ≤ 53.23
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol?
The IUPAC name of trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol (CID 140776898) is trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol.
What is the SMILES notation for trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol?
The canonical SMILES for trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol is C[Si](C)(C)CCOCn1nc(Br)c2c(N[C@@H]3CCC[C@H]3O)ncnc21.
What is the InChIKey of trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol?
The InChIKey is LIXLKDPJQBKEEG-VXGBXAGGSA-N. The full InChI is InChI=1S/C16H26BrN5O2Si/c1-25(2,3)8-7-24-10-22-16-13(14(17)21-22)15(18-9-19-16)20-11-5-4-6-12(11)23/h9,11-12,23H,4-8,10H2,1-3H3,(H,18,19,20)/t11-,12-/m1/s1.
What are the key properties of trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol?
trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol has a molecular weight of 428.41 g/mol, XLogP of 3.23, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1R,2R)-2-[[3-bromo-1-(2-trimethylsilylethoxymethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclopentan-1-ol is sourced from PubChem (CID 140776898), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).